Compare OPK & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | DRD |
|---|---|---|
| Founded | 2007 | 1895 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 2.3B |
| IPO Year | 1995 | N/A |
| Metric | OPK | DRD |
|---|---|---|
| Price | $1.30 | $34.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $2.28 | ★ $27.50 |
| AVG Volume (30 Days) | ★ 4.0M | 358.5K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | N/A | ★ 68.66 |
| EPS | N/A | ★ 1.46 |
| Revenue | ★ $642,067,000.00 | $443,674,785.00 |
| Revenue This Year | N/A | $18.10 |
| Revenue Next Year | N/A | $25.92 |
| P/E Ratio | ★ N/A | $23.38 |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $1.11 | $8.77 |
| 52 Week High | $2.04 | $35.05 |
| Indicator | OPK | DRD |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 64.82 |
| Support Level | $1.24 | $31.17 |
| Resistance Level | $1.38 | $32.84 |
| Average True Range (ATR) | 0.05 | 1.21 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 37.04 | 89.39 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.